The Globe and Mail reports in its Friday, Aug. 2, edition that RBC Capital analyst Drew McReynolds is keeping his "sector perform" recommendation for Thomson Reuters intact. The Globe's David Leeder writes that Mr. McReynolds gave his share target a $2 (U.S.) trim to $168 (U.S.). Analysts on average target the shares at $163.81 (U.S.). Mr. McReynolds says in a note: "At current valuation (FTM EV/EBITDA of 25.1 times), we believe the bar to deliver consolidated organic revenue growth in excess of 6 per cent has risen with the organic revenue growth trajectory over the 2025-2026 period now taking centre stage. While we remain patient for more timely and/or attractive accumulation points, we believe current valuation levels (i.e., 20-25 times FTM EV/EBITDA) are fundamentally justified provided: (i) management meets or exceeds a 7-8-per-cent organic revenue growth trajectory by 2026 without meaningful changes to the company's current margin, capex and FCF conversion profile; (ii) solid execution on the GenAI playbook continues with little change to the current GenAI narrative including perceived opportunities and risks; and (iii) the valuation impact of interest rate expectations/bond yields is at worst neutral."